Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Yamazaki, Tomoko  [Clear All Filters]
2024
Mochizuki M, Shibuya-Takahashi R, Kanno S-I, Adachi S, Fujimori H, Nakazato A, Fujii K, Morita S, Saijoh S, Yamazaki T, et al. CD271 mRNA/hnRNPA2B1 complex promotes proliferation and stemness in oral and head and neck squamous cell carcinoma. Cancer Sci. 2024.
2023
Miyabe S, Ito S, Sato I, Abe J, Tamai K, Mochizuki M, Fujimori H, Yamaguchi K, Shindo N, Shima H, et al. Clinical and genomic features of non-small cell lung cancer occurring in families. Thorac Cancer. 2023.
2022
Nakazato A, Mochizuki M, Shibuya-Takahashi R, Fujimori H, Fujii K, Saijoh S, Morita S, Yamazaki T, Imai T, Sato I, et al. RELA is required for CD271 expression and stem-like characteristics in hypopharyngeal cancer. Sci Rep. 2022;12(1):17751.
2021
Saijoh S, Nakamura-Shima M, Shibuya-Takahashi R, Ito R, Sugawara A, Yamazaki T, Imai T, Asada Y, Matsuura K, Iwai W, et al. Discovery of a chemical compound that suppresses expression of BEX2, a dormant cancer stem cell-related protein. Biochem Biophys Res Commun. 2021;537:132-139.
2020
Morita S, Mochizuki M, Shibuya-Takahashi R, Nakamura-Shima M, Yamazaki T, Imai T, Asada Y, Matsuura K, Kawamura S, Yamaguchi K, et al. Establishment of a Monoclonal Antibody That Recognizes Cysteine-Rich Domain 1 of Human CD271. Monoclon Antib Immunodiagn Immunother. 2020;39(1):6-11.
2019
Morita S, Mochizuki M, Wada K, Shibuya R, Nakamura M, Yamaguchi K, Yamazaki T, Imai T, Asada Y, Matsuura K, et al. Humanized anti-CD271 monoclonal antibody exerts an anti-tumor effect by depleting cancer stem cells. Cancer Lett. 2019.